B

BRCR Global | Tamarac, FL

Research site

(Unclaimed)

Location

7431 N University Drive Suite 108, Tamarac, Florida, United States of America

Site insights

Top conditions

Top treatments

Cemiplimab

ONM-501

Zongertinib

Parent organization

This site is a part of BRCR Global

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 3 total trials

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. (ON-5001)

A phase 1, multicenter, open label, non-randomized dose escalation and dose expansion study to examine the maximum tolerated dose, (MTD), minimum eff...

Enrolling

Uveal Melanoma, Recurrent

Mantle Cell Lymphoma

Drug: Cemiplimab

Drug: ONM-501

Locations recently updated

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

This is a study for people with advanced cancer for whom previous treatment was not successful. Adults aged 18 and over with advanced cancer with HER...

Enrolling

Solid Tumours

Drug: Zongertinib

Phase III Study of AK112 for NSCLC Patients

A Randomized, Double-blind, Multi-center, Phase III Clinical Study of AK112 or Placebo Combined With Pemetrexed and Carboplatin in Patients With EGFR...

Active, not recruiting

Non-Squamous Non-small Cell Lung Cancer

Drug: Placebo Injection

Drug: AK112 Injection

Trial sponsors

O

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms